NIH-funded research R01 grant

Understanding how parainfluenza virus replicates its genome

Official title: Mechanism of parainfluenza virus genome replication

Funded at Boston University Medical Campus · NIH-11168265 · Data updated 2026-11-12

This study is looking at how the parainfluenza virus makes copies of itself, which can help us find better treatments for respiratory infections caused by this virus and others like it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startMarch 1, 2025
Project endFebruary 28, 2030
Funding year2025
Award (this year)$734,184
NIH project number1R01AI191462-01
Project IDNIH-11168265 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation or benefit from this research would include individuals at risk for parainfluenza virus infections, such as young children, the elderly, and those with compromised immune systems.

Less likely to help

Patients who are not affected by parainfluenza virus infections or who do not have underlying health conditions that increase their risk may not receive benefit from this research.

What this research studies

This research investigates the mechanisms behind the replication of the parainfluenza virus, which is known to cause respiratory infections. The team will focus on the viral polymerase complex, which is crucial for the virus's ability to replicate and produce its genetic material. By studying the structure and function of this complex, the researchers aim to uncover new insights that could lead to the development of effective antiviral therapies. Patients may benefit from this research as it could lead to improved treatments for viral infections caused by parainfluenza and similar viruses.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antiviral therapies that effectively combat parainfluenza virus infections.

How similar studies have gone: Other research has shown success in targeting viral polymerase complexes for antiviral development, indicating that this approach has potential.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Fearns, Rachel — Boston University Medical Campus
  • Study coordinator: Fearns, Rachel

Related research

Other NIH-funded projects on the same topics.

  • Creating a detailed map of early lung cancer changes

    This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.

    NIH research Boston University Medical Campus · Boston, United States · NIH-9627274

  • Telomere trouble in ALT cancers: what causes damage and how it happens

    Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11630744

  • IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV

    This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11604270

  • IL-6 signaling and lung injury after TB and HIV co-infection

    This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11604269

  • LEAD Africa: advancing Alzheimer’s research across Africa

    A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11599552

  • Leading AD and related dementias research in Africa

    A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11599551

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.